Order Article Reprints

Na Y-J, Choi KJ, Jung WH, Park SB, Kang S, Ahn JH, Kim KY. A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome. International Journal of Molecular Sciences. 2020; 21(10):3729. https://doi.org/10.3390/ijms21103729

Na, Yoon-Ju, Kyoung Jin Choi, Won Hoon Jung, Sung Bum Park, Sein Kang, Jin Hee Ahn, and Ki Young Kim. 2020. "A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome" International Journal of Molecular Sciences 21, no. 10: 3729. https://doi.org/10.3390/ijms21103729

Na, Y.-J., Choi, K. J., Jung, W. H., Park, S. B., Kang, S., Ahn, J. H., & Kim, K. Y. (2020). A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome. International Journal of Molecular Sciences, 21(10), 3729. https://doi.org/10.3390/ijms21103729